Recruiting at 1 site No phase Hyperlipidemia

Clinical trial for Hyperlipidemia

Official title Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease

ClinicalTrials.gov ID: NCT07334834

What this study is testing

What it's testing
The study wants to find out if using a computer guide and a team of health workers helps lower LDL (bad) cholesterol better than standard care.
Who it's for
This study is looking for people who have atherosclerotic cardiovascular disease, which is a condition where arteries are narrowed by plaque.
What's involved
Participants will be assigned to either a new management strategy using a computer algorithm and a multi-professional team, or to usual care.
Time commitment
The source text does not specify the duration or number of visits required.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Provided informed consent
  • Age \>18 years inclusive at screening
  • Coronary artery disease (prior revascularization, myocardial infarction, imaging evidence of coronary atherosclerosis)
  • Peripheral artery disease (prior revascularization, amputation, ankle: brachial index (ABI) ≤ 0.90, imaging evidence of extra-coronary...
  • Carotid artery disease (prior endarterectomy or stenting of the extracranial carotid artery or imaging evidence of carotid atherosclerosis)

You likely can't join if

  • Any reason that, in the opinion of the investigator, the patient would be unable to adhere to the protocol for the duration of the study (e.g.
  • Planned active titration of current lipid-lowering therapy
  • Myocardial infarction or arterial revascularization within prior 30 days
See the full eligibility criteria
Who can join
  • Provided informed consent
  • Age \>18 years inclusive at screening
  • Coronary artery disease (prior revascularization, myocardial infarction, imaging evidence of coronary atherosclerosis)
  • Peripheral artery disease (prior revascularization, amputation, ankle: brachial index (ABI) ≤ 0.90, imaging evidence of extra-coronary atherosclerosis)
  • Carotid artery disease (prior endarterectomy or stenting of the extracranial carotid artery or imaging evidence of carotid atherosclerosis)
  • Imaging evidence of atherosclerotic vascular disease in a non-coronary vascular bed (e.g. aorta, mesenteric, renal)
  • LDL-C \>70mg/dL
What rules you out
  • Any reason that, in the opinion of the investigator, the patient would be unable to adhere to the protocol for the duration of the study (e.g.
  • Planned active titration of current lipid-lowering therapy
  • Myocardial infarction or arterial revascularization within prior 30 days

The study team makes the final eligibility decision.

Where it is enrolling

  • Aurora, Colorado, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Aurora, Colorado, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.